DK613989A - Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning - Google Patents

Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning Download PDF

Info

Publication number
DK613989A
DK613989A DK613989A DK613989A DK613989A DK 613989 A DK613989 A DK 613989A DK 613989 A DK613989 A DK 613989A DK 613989 A DK613989 A DK 613989A DK 613989 A DK613989 A DK 613989A
Authority
DK
Denmark
Prior art keywords
tromotoric
preparation
gas
effect
substituted benzamides
Prior art date
Application number
DK613989A
Other languages
English (en)
Other versions
DK613989D0 (da
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of DK613989D0 publication Critical patent/DK613989D0/da
Publication of DK613989A publication Critical patent/DK613989A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
DK613989A 1988-12-14 1989-12-06 Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning DK613989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8816433A FR2640139A1 (fr) 1988-12-14 1988-12-14 Application de benzamides substitues comme gastromoteurs

Publications (2)

Publication Number Publication Date
DK613989D0 DK613989D0 (da) 1989-12-06
DK613989A true DK613989A (da) 1990-06-15

Family

ID=9372914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK613989A DK613989A (da) 1988-12-14 1989-12-06 Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning

Country Status (9)

Country Link
US (1) US5116857A (da)
EP (1) EP0374029B1 (da)
JP (1) JPH02237928A (da)
AT (1) ATE73997T1 (da)
CA (1) CA2005442A1 (da)
DE (1) DE68901085D1 (da)
DK (1) DK613989A (da)
FR (1) FR2640139A1 (da)
GR (1) GR3004350T3 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
US6662951B1 (en) * 2000-09-27 2003-12-16 Basic Resources, Inc. Process for extracting and purifying naturally occurring zeolite
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US8334281B2 (en) * 2008-12-22 2012-12-18 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA3047088A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (da) * 1961-07-25
CA1082181A (en) * 1976-06-03 1980-07-22 Eric A. Watts Benzamide derivatives
US4188393A (en) * 1977-04-22 1980-02-12 Sandoz Ltd. Treating spastic conditions or relaxing muscles
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
JPH0710771B2 (ja) * 1984-10-23 1995-02-08 ナステツク フア−マス−テイカル カンパニ−、インコ−ポレイテツド 抗吐き気および抗嘔吐薬剤の新規な投与組成物
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
SK289787A3 (en) * 1986-04-30 1998-06-03 Dainippon Pharmaceutical Co Substituted n-£(2-morpholinyl)alkyl|benzamide derivative, method of producing the same and a pharmaceutical composition on its base
DE3782651T2 (de) * 1987-06-17 1993-03-25 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl)-2-methoxy-4((1-h-4,5-dihydro-2-imidazolyl)amino)-5-chlorobenzamid als anxiolytisches und antipsychotisches mittel.
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides

Also Published As

Publication number Publication date
JPH02237928A (ja) 1990-09-20
ATE73997T1 (de) 1992-04-15
DE68901085D1 (de) 1992-04-30
EP0374029B1 (fr) 1992-03-25
US5116857A (en) 1992-05-26
GR3004350T3 (da) 1993-03-31
CA2005442A1 (fr) 1990-06-14
FR2640139A1 (fr) 1990-06-15
EP0374029A1 (fr) 1990-06-20
DK613989D0 (da) 1989-12-06

Similar Documents

Publication Publication Date Title
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
DK499088D0 (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
ES488788A0 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
PT91575A (pt) Procede de preparation de benzylamines disubstituees utiles comme medicaments
SE8600413L (sv) Nytt lekemedel och sett att framstella detsamma
DK613989D0 (da) Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2069719T3 (es) Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2058849T3 (es) Benzanilidas.
AU7134191A (en) Novel propanamines, their pharmacological properties and their application for therapeutic, in particular antidiarrhoeal, purposes
AT388373B (de) Neue thyroninderivate
DK0508955T3 (da) Anvendelse af 2-iminothiazolidin-4-onderivater som nye lægemidler
DK228086A (da) Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater
ES8107206A1 (es) Procedimiento para obtener derivados de tiazol
ES2063157T3 (es) Nuevos derivados del indol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE8400629L (sv) Basiska oximetrar
GR3008034T3 (da)
DK614089D0 (da) Anvendelse af substituerede benzamider til fremstilling af laegemidler med anxiolytisk og antipsykotisk virkning
FI910894A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-sykloalkyylialkyyliamiinien valmistamiseksi
SE7712447L (sv) Sett att framstella nya bensofenonderivat
DK0424248T3 (da) 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf
ES2052945T3 (es) Derivados de la 20,21-dinoreburnamenina sustituidos en 15 con un grupo aminado y sus sales, su procedimiento de preparacion y los productos intermedios asi obtenidos, su aplicacion como medicamentos, y las composiciones farmaceuticas que los contienen.
ES8704922A2 (es) Procedimiento de obtencion de nuevos derivados de -(alquilaminopropionil)-tiofeno sustituidos en el anillo tiofenico
ATE36536T1 (de) Phosphoroimidate.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment